Review Article
Volume 11 Issue 7 - 2020
Beyond COVID-19, the Possible Impact on Eye Health
Nnenne U Onu1*, Okechi U Amaechi1, Andrew U Omaka1, Amarachi C Ezeigbo1, Christopher O Timothy1, Samuel O Ndukuba1, Jacqueline E Obioma-Elemba2 and Ngozi O Onu3
1Department of Optometry, Abia State University, Uturu, Nigeria
2Department of Optometry, Imo State University, Owerri, Nigeria
3Pharmacy Department, State House Medical Centre, Abuja, Nigeria
*Corresponding Author: Nnenne U Onu, Department of Optometry, Abia State University, Uturu, Nigeria.
Received: May 02, 2020; Published: June 19, 2020


The disease, COVID-19 has brought a lot of untold hardships to people, affecting persons from all cadres of human existence and causing a great deal of tragedy to nations. The race to halt this unseen enemy has gained momentum. This is seen in many trials, which are currently re-evaluating existing drugs and possibly new ones aimed at stopping this global pandemic. One of the alternative drugs which has been repurposed is an antimalarial known as chloroquine and its analogue-hydroxychloroquine. This drug with its analogue has documented side effects with prolonged use, increased dosage and in persons with renal failure, with effects especially on the eyes which can even lead to irreversible blindness. What then could be the possible impact of this drug on those receiving this type of treatment during the course of their therapy for COVID-19?

Keywords: COVID-19; Hydroxychloroquine; Chloroquine


  1. Patel A JD. “Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020”. Morbidity and Mortality Weekly Report 69 (2020): 140-146.
  2. The Open cancelled; Masters, US Open and US PGA Championship rescheduled (2020).
  3. “Watchdog report finds severe shortages and significant challenges to hospital's coronavirus responses”. CNN Politics (2020).
  4. Zhao S., et al. “Estimating the Unreported Number of Novel Coronavirus (2019-nCoV) Cases in China in the First Half of January 2020: A Data-Driven Modelling Analysis of the Early Outbreak”. Journal of Clinical Medicine 2 (2020).
  5. “British PM's condition has worsened, 10 Downing says, a day after he was hospitalized for coronavirus” (2020).
  6. “Hand Hygiene in Healthcare Settings” (2020).
  7. Rubin EJ., et al. “Audio Interview: New Research on Possible Treatments for Covid-19”. The New England Journal of Medicine 12 (2020): e30.
  8. Farooq U. “Effectiveness of Hydroxychloroquine in Covid-19 Patients (Covid)”. Clinical Trials (2019).
  9. Atluri S., et al. “Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use”. Pain Physician2 (2020): E71-E83.
  10. Kupferschmidt K and J Cohen. “Race to find COVID-19 treatments accelerates”. Science6485 (2020): 1412.
  11. Keyaerts E., et al. “Antiviral Activity of Chloroquine against Human Coronavirus OC43 Infection in Newborn Mice”. Antimicrobial Agents and Chemotherapy8 (2009): 3416-3421.
  12. Savarino A., et al. “Effects of chloroquine on viral infections: an old drug against today's diseases?” The Lancet Infectious Diseases 11 (2003): 722-727.
  13. Akpovwa H. “Chloroquine could be used for the treatment of filoviral infections and other viral infections that emerge or emerged from viruses requiring an acidic pH for infectivity”. Cell Biochemistry and Function4 (2006): 191-196.
  14. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]”. Zhonghua Jie He He Hu Xi Za Zhi3 (2020): 185-188.
  15. Gao J., et al. “Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies”. Biosci Trends1 (2020): 72-73.
  16. Richman D., et al. “Clinical virology 2017”. Washington DC: ASM Press (2017).
  17. Burrel S., et al. “Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey”. Antiviral Research 100 (2013): 365-372.
  18. “Japan to trial HIV antiretroviral drugs on Covid-19 patients”. The Guardian (2020).
  19. O'Day R., et al. “Ophthalmologic complications of antiviral therapy in hepatitis C treatment”. World Journal of Gastroenterology 45 (2013): p8227-8237.
  20. Jacobson M., et al. “Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy”. Lancet 349 (1997): 1143-1145.
  21. Balba G., et al. “Ocular syphilis in HIV-positive patients receiving highly active antiretroviral therapy”. Journal of Medicinal Chemistry 119 (2006): 21-25.
  22. Bae EJ., et al. “Retinal Damage in Chloroquine Maculopathy, Revealed by High Resolution Imaging: A Case Report Utilizing Adaptive Optics Scanning Laser Ophthalmoscopy”. Korean Journal of Ophthalmology 1 (2014): 100-107.
  23. Kanski JJ. “Clinical Ophthalmology A systemic approach”. 6th, London: Butterworth Heineman Elsevier (2007).
  24. Khuruana AK. “Comprehensive Ophthalmology”. 4th , New Delhi: New Age International (P) Limited, Publishers (2007).
  25. Yusuf IH., et al. “Hydroxychloroquine retinopathy”. Eye 6 (2017): 828-845.
  26. Bennet PN., et al. “Clinical Pharmacology”. 11th London: Churchill Livingstone- Elsevier (2012).
  27. Neil MJ. “Medical pharmacology at a glance”. 4th Blackwell Science (2002): 91.
  28. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) (2020).
  29. “South Korea: More recovered coronavirus patients test positive” (2020).
Citation: Onu, N.U., et al. “Beyond COVID-19, the Possible Impact on Eye Health”. EC Ophthalmology 11.7 (2020): 67-72.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

February Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the February issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before February 23, 2023.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.